2 results
Approved WMOPending
To compare the efficacy of the L300 with a conventional AFO or orthopedic shoes with regard to walking capacity in stroke patients suffering from a drop foot.
Approved WMORecruiting
In 2013 the Boston Scientific VERCISE System has obtained regulatory approval for use in the European Union, CE mark was granted for the treatment of intractable primary and secondary dystonia.The objective of the study is to compile characteristics…